Navigation Links
Study shows decisions over life-sustaining treatment are likely to change
Date:9/26/2011

Amsterdam, The Netherlands: Patients with chronic conditions are likely to change their preferences for receiving emergency procedures in the event of cardiac arrest, according to new findings.

The study, which will be presented at the European Respiratory Society Annual Congress in Amsterdam today (26 September 2011), suggests that different factors could influence patients' decisions to undergo life-sustaining treatments, but this will often go unnoticed by their healthcare provider.

Cardiopulmonary resuscitation (CPR) is an emergency procedure involving chest compressions, which is used to restore blood circulation in a person having a cardiac arrest. Similarly, mechanical ventilation can also be used to help a patient to breathe when their spontaneous breathing function is not working.

When patients have been diagnosed with a potentially life-limiting illness, they are able to decide in advance, after a discussion with their doctor, whether they are happy for these procedures to be used in the event of a cardiac arrest.

The research analysed 206 patients who had chronic obstructive pulmonary disease (COPD), chronic heart failure or chronic renal failure but were in a stable condition when the study began. They monitored patients every four months for a year and assessed their preferences for CPR and mechanical ventilation.

The researchers also assessed a number of health and lifestyle factors, including presence of other diseases, hospital admission, health status, care dependency, mobility, depression and anxiety, in order to determine if these factors could be linked with changes in patients' preferences for life-sustaining treatments.

The results showed that 38% of people changed their preferences for CPR and / or mechanical ventilation over the year. This has significant implications for clinical care as healthcare providers need to be aware of the fact that these preferences should be evaluated regularly.

The results also showed that patients were more likely to change their preferences if they experienced a change in health status, mobility, symptoms of anxiety and depression or marital status.

Dr Daisy Janssen, lead author from the CIRO+, Centre of Expertise for Chronic Organ Failure, in the Netherlands, said: "Our findings have given us a key insight into how patients' preferences change regarding life-sustaining treatments. We suggest that regular re-evaluation of advance care planning is necessary when patients experience a change in health status, mobility, symptoms of anxiety and depression or marital status."


'/>"/>

Contact: Lauren Anderson
lauren.anderson@europeanlung.org
31-610-860-810
European Lung Foundation
Source:Eurekalert

Related medicine news :

1. Despite Treatment, Employees with Depression Generate Higher Absentee Costs, According to Thomson Reuters Study
2. American Council on Exercise (ACE) Study Reveals Kettlebells Provide Powerful Workout in Short Amount of Time
3. TV drama can be more persuasive than news program, study finds
4. Study carried out into biological risks of eating reptiles
5. Neuroimaging study may pave way for effective Alzheimers treatments
6. Study finds racial gaps continue in heart disease awareness
7. Luth Researchs IndicatorEDG(TM) Study Finds Americans Hopes of Achieving Their Dreams Are Fading
8. First blinded study of venous insufficiency prevalence in MS shows promising results
9. Soothing infants with food focus of childhood obesity study
10. People with anxiety disorder less able to regulate response to negative emotions, study shows
11. American Heart Association Rapid Access Journal Report: Study Finds Racial Gaps Continue in Heart Disease Awareness, Low Knowledge of Heart Attack Warning Signs Among Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... TX (PRWEB) , ... February 27, 2017 , ... ... 75,000 customer threshold mark last week. In addition, Discount Power's RCE (Residential Customer ... Energy LLC in March 2014. The company had 800 customers and 2,250 RCEs ...
(Date:2/27/2017)... ... February 27, 2017 , ... Silicon Valley Hair ... announce a new informational post on robotic hair transplantation. San Francisco residents may ... transplant and Follicular Unit Transplantation (FUT) can sound similar. Either treatment can be ...
(Date:2/27/2017)... ... ... New Jersey ranks among the top five states in the entire nation ... advanced services is growing. , Project WE vs C is a focused two-year ... non-profit partners in their fight against cancer and in support of their shared mission ...
(Date:2/26/2017)... Como, Italy (PRWEB) , ... February 26, 2017 ... ... its last call for entries to the 7th Edition of International Social Design ... by Social Design Professionals, Product Designers, System Designers, Governments and Institutions worldwide with ...
(Date:2/26/2017)... ... February 26, 2017 , ... NuevaCare, a leading home care agency based in ... Palo Alto, is proud to announce an important upgrade to its geographic information pages, ... care close to home, and by having city-specific pages, NuevaCare is answering that information ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... , Australie, le 24 février 2017 ITL Limited, ... santé diversifiée innovante, est ravie d,annoncer les excellents résultats ... la période précédente correspondante. Une présentation complète « Résultats et ... être consultée ici . Faits ... de 2,12 millions $ (Déc. 2015 : 1,04 million $ ; en hausse de ...
(Date:2/24/2017)... , Feb. 23, 2017 ... insights on the various drugs being developed ... covers all the drugs that are in ... Clinical). The pipeline focuses on novel pharmacologic ... antibodies, stem cell therapies, recombinant proteins and ...
(Date:2/24/2017)... Feb. 24, 2017  Xynomic Pharmaceuticals, Inc., an oncology ... it has acquired exclusive worldwide rights to develop, ... HDAC inhibitor targeting hematological and solid tumors. ... 1 and 2 clinical trials of Abexinostat in ... have already been completed, demonstrating that Abexinostat is ...
Breaking Medicine Technology: